Based on recent news and more, here are a handful of marijuana related stocks worth keeping an eye on as North American markets kick off trading on Thursday, August 24th.
Canadian Bioceutical Corp. (CSE:BCC)(OTC:CBICF)(FRA:5CB)
This morning, Canadian Bioecutical released the company's bi-weekly update on the status of their management cease trade order. Two officers from the company are prohibited in trading in the company's shares until two business days after they release audited financial statements for the year ended March 31, 2017. BCC previously announced that they expect to complete and release the aforementioned financial statements before August 31st, however in today's update they mentioned the possibility of not completing them by the 31st. We'll be watching to see how the market reacts to this news of the possibility of an additional delay in their required filings.
Related: Canadian Bioceutical Relocates Arizona Dispensary
Canada House Wellness Group Inc. (CSE:CHV)(OTC:SARSF)(FRA:509A)
Earlier, Canada House Wellness Group announced that the company has closed the second tranche of its convertible debenture financing and that their Marijuana For Trauma clinic division has fully implemented its Cannabis Patient Management software across of all of their 11 locations. The company has also signed a deal to provide this software to a US-based cannabis clinic service company. We'll be keeping an eye on shares of Canada House Wellness Corp. on the closing of their financing and progress in their technology unit.
Related: Canada House Wellness Acquires Knalysis Technologies
CannaRoyalty Corp. (CSE:CRZ)(OTC:CNNRF)(FRA:CY4)
After the close of trading yesterday, CannaRoyalty announced that the company has closed their $12 million financing from Sprott, as part of their previously announced cannabis financing joint venture. This morning, CannaRoyalty released their financial results for the second quarter of 2017. We'll be watching to see how the market reacts to their earnings release, and the news of a completed financing.
Related: CannaRoyalty Closes $12 Million Financing From Sprott
Marapharm Ventures Inc. (CSE:MDM)(OTC:MRPHF)(FRA:2M0)
Marapharm Ventures released the company's restated financial results and MD&A for the nine months ended December 31, 2016 this morning. We'll be keeping a close eye on shares of Marapharm as the markets digest their restated financials.
Related: Marapharm's Washington and Nevada Facilities Progressing
MassRoots Inc. (OTC:MSRT)
Yesterday evening, MassRoots announced that the company is acquiring CannaRegs, a technology-enabled tracker of changes in cannabis regulations at the municipal, local and state levels, for approximately $12 Million in stock. We'll be keeping an eye on shares of MassRoots as they open for trading today (remember, there were big gains heading into the announcement and conference call yesterday).
Related: MassRoots' July Investor Deck and Shareholders' Letter
THC Biomed International Ltd. (CSE:THC)(OTC:THCBF)(FRA:TFHD)
This morning, THC Biomed announced that the company has received their license to sell dried cannabis from Health Canada. They previously only had a license to sell starting materials, along with a cultivation license. Shares of THC Biomed were a big gainer heading into this announcement, and we'll be watching to see if yesterday's gains continue today.
Related: You Can't Grow Cannabis Without Starting Materials
That's all for now, but we'll be sure to keep readers posted regarding important developments in these names and in the cannabis industry worldwide. Be sure to subscribe to one or more of our free newsletters so you never miss an important marijuana update. Don't be a stranger; connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.